LivePerson appoints Nathan “Tripp” Lane to Board, term to 2026

LivePerson (LPSN) appointed Nathan “Tripp” Lane to its Board as a Class II director effective November 7, 2025, with a term expiring at the 2026 Annual Meeting of Stockholders.

Rhea-AI Filing Summary

LivePerson (LPSN) appointed Nathan “Tripp” Lane to its Board as a Class II director effective November 7, 2025, with a term expiring at the 2026 Annual Meeting of Stockholders. He was nominated pursuant to the previously announced Exchange Agreement with former holders of the Company’s 0% Senior Convertible Notes due 2026, following the Company’s standard governance review. Committee assignments will be disclosed later. Lane will receive standard annual director fees and benefits and an initial equity grant under the Amended and Restated 2019 Stock Incentive Plan. The Company intends to enter into its standard director indemnification agreement with him.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did LivePerson (LPSN) announce?

LivePerson appointed Nathan “Tripp” Lane as a Class II director effective November 7, 2025, with a term through the 2026 Annual Meeting.

Why was Nathan “Tripp” Lane nominated to the LPSN board?

He was nominated under the Exchange Agreement with former holders of the Company’s 0% Senior Convertible Notes due 2026, and approved via standard governance processes.

What are Nathan Lane’s committee assignments at LivePerson?

Committee appointments will be disclosed later by the Company.

What compensation will the new director receive at LPSN?

Lane will receive standard annual director fees and benefits and an initial equity grant under the Amended and Restated 2019 Stock Incentive Plan.

Will LivePerson provide indemnification for the new director?

Yes. The Company intends to enter into its standard director and executive officer indemnification agreement with Lane.

What is Nathan Lane’s professional background?

Lane founded Delancey Cove LLC and has served on several public and private company boards; prior roles include BlueMountain Capital and Apax Partners.

When does Nathan Lane’s term on the LPSN board end?

His current term expires at the 2026 Annual Meeting of Stockholders.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/14/2025 - 04:19 PM Learn about SEC filing dates

0001102993false00011029932025-11-072025-11-070001102993us-gaap:CommonStockMember2025-11-072025-11-070001102993us-gaap:RightsMember2025-11-072025-11-07

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549 

_____________________

FORM 8-K

____________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

  Date of Report (Date of earliest event reported): November 7, 2025

LivePerson, Inc.

(Exact Name of Registrant as Specified in its Charter)

Delaware			001-41926			13-3861628
(State or other jurisdiction of incorporation)			(Commission File Number)			(I.R.S. Employer Identification No.)

530 7th Ave, Floor M1

New York, New York 10018

(Address of principal executive offices, with zip code)

(212) 609-4200

Registrant’s telephone number, including area code

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, par value $0.001 per share			LPSN			The Nasdaq Stock Market LLC
Rights to Purchase Series A Junior Participating Preferred Stock			None			The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On November 7, 2025, the Board of Directors (the “Board”) of LivePerson, Inc. (the “Company”) appointed Nathan “Tripp” Lane as a Class II director of the Board, with a term expiring as of the Company’s 2026 Annual Meeting of Stockholders. Mr. Lane was nominated pursuant to the terms of the previously announced Exchange Agreement, dated August 11, 2025 (the “Exchange Agreement”), by and among the Company and certain former holders (each, a “Noteholder”, and collectively, the “Noteholders”) of the Company’s 0% Senior Convertible Notes due 2026 (the “2026 Notes”), together with thorough review pursuant to the Company’s standard nominating and corporate governance processes. Any committee appointments for Mr. Lane will be subsequently disclosed.

Mr. Lane is the founder of Delancey Cove LLC, a consulting firm. Mr. Lane has also served as a director for a number of public and private companies since 2019, including as a non-executive director of Card Factory PLC from 2020 to 2024, National Cinemedia from 2024 to 2025, and Benchmark Holdings PLC from 2024 to 2025. Prior to Delancey Cove, Mr. Lane was an investment professional with BlueMountain Capital Management, LLC, a hedge fund, from 2015 to 2017, and a Principal at Apax Partners, L.P., a global private equity advisory firm, from 2006 to 2015 where he focused on investments in the consumer, retail and media industries. Mr. Lane holds a B.A. from Colgate University, an M.A. from the School of Advanced International Studies (SAIS), Johns Hopkins University, and an M.B.A. from The Wharton School, University of Pennsylvania.

Mr. Lane will receive standard annual director fees and benefits, as well as an initial grant of equity under the Company’s Amended and Restated 2019 Stock Incentive Plan. Mr. Lane is not a party to any transaction, or series of transactions, required to be disclosed pursuant to Item 404(a) of Regulation S-K.

The Company intends to enter into its form of director and executive officer indemnification agreement with Mr. Lane, a copy of which has been filed as Exhibit 10.6 to the Company’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission on March 13, 2012.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:    November 14, 2025                

LIVEPERSON, INC.

(Registrant)

By:    /s/ MONICA L. GREENBERG    

Monica L. Greenberg

Executive Vice President, Policy and General Counsel